The Trump administration has a new plan to reduce Americans' out-of-pocket drug bills. It's sure to face opposition from entrenched special interests. But if the administration succeeds in implementing the plan, patients will greatly benefit.
The proposed rule would reform how drug companies and insurers interact, especially in Medicare's Part D prescription benefit, which covers about 45 million seniors and Americans with disabilities. The government doesn't administer its own prescription plans. Instead, it allows private insurers to sell coverage to beneficiaries.